How do immune cells overcome the blood-brain barrier in multiple sclerosis?

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · see citing works

Astrocyte-endothelial interactions at the blood-brain barrier

Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · see citing works

IL-17 and th17 cells

Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · see citing works

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · see citing works

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Polman, C., O'Connor, P., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J., Lublin, F., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,293 · see citing works

The blood-brain barrier/neurovascular unit in health and disease

Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · see citing works

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Kappos, L., Radue, E., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,569 · see citing works

JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN

Brightman, M., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,457 · see citing works

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Cohen, J. A., Barkhof, F., Comı, G., Hartung, H., Khatri, B. O., Montalbán, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,199 · see citing works

Pericytes are required for blood–brain barrier integrity during embryogenesis

Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128 · see citing works

Matrix metalloproteinases as modulators of inflammation and innate immunity

Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929 · see citing works

IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells

Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,841 · see citing works

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · see citing works

Untitled work

(1991) · Medical Entomology and Zoology · Cited by 1,512 · see citing works

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K., Tian, Q., Watowich, S. S., Jetten, A. M., et al. (2007) · Nature · doi:10.1038/nature05969 · Cited by 1,466 · see citing works

Generation of pathogenic TH17 cells in the absence of TGF-β signalling

Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388 · see citing works

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J. A., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,180 · see citing works

TNF neutralization in MS

The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,060 · see citing works

Three or more routes for leukocyte migration into the central nervous system

Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052 · see citing works

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

Giovannoni, G., Comı, G., Cook, S. D., Rammohan, K. W., Rieckmann, P., Sørensen, P. S., Vermersch, P., Chang, P., Hamlett, A., Musch, B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902533 · Cited by 1,021 · see citing works

IL-21 and TGF-β are required for differentiation of human TH17 cells

Yang, L., Anderson, D. E., Baecher‐Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 926 · see citing works

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

Dutta, R., McDonough, J., Yin, X., Peterson, J. W., Chang, A., Torres, T., Gudz, T. I., Macklin, W. B., Lewis, D., Fox, R., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 881 · see citing works

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

Matusevičius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V., Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751 · see citing works

Prolonged activation of jun and collagenase genes by tumour necrosis factor-α

Brenner, D. A., O'Hara, M., Angel, P. E., Chojkier, M., & Karin, M. (1989) · Nature · doi:10.1038/337661a0 · Cited by 717 · see citing works

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A., & John, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808698106 · Cited by 666 · see citing works

The large apparent work capability of the blood‐brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat

Oldendorf, W. H., Cornford, M. E., & Brown, W. J. (1977) · Annals of Neurology · doi:10.1002/ana.410010502 · Cited by 651 · see citing works

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis

Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., Opdenakker, G., & Sorokin, L. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051342 · Cited by 559 · see citing works

Human cerebrospinal fluid central memory CD4 + T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin

Kivisäkk, P., Mahad, D., Callahan, M. K., Trebst, C., Tucky, B. H., Wei, T., Wu, L., Bækkevold, E. S., Lassmann, H., Staugaitis, S. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433000100 · Cited by 546 · see citing works

Cellular mechanisms of IL-17-induced blood-brain barrier disruption

Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-141978 · Cited by 529 · see citing works

Tight Junctions of the Blood–Brain Barrier

Kniesel, U., & Wolburg, H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006995910836 · Cited by 525 · see citing works

What is the blood–brain barrier (not)?

Bechmann, I., Galea, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.007 · Cited by 520 · see citing works

Endothelial Cell Laminin Isoforms, Laminins 8 and 10, Play Decisive Roles in T Cell Recruitment across the Blood–Brain Barrier in Experimental Autoimmune Encephalomyelitis

Sixt, M., Engelhardt, B., Pausch, F., Hallmann, R., Wendler, O., & Sorokin, L. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.933 · Cited by 509 · see citing works

Basic principles of immunological surveillance of the normal central nervous system

Hickey, W. F. (2001) · Glia · doi:10.1002/glia.1101 · Cited by 476 · see citing works

SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier

Lee, S., Kim, W. J., Choi, Y. K., Song, H. S., Son, M. J., Gelman, I. H., Kim, Y.-J., & Kim, K. (2003) · Nature Medicine · doi:10.1038/nm889 · Cited by 473 · see citing works

The double-edged role of nitric oxide in brain function and superoxide-mediated injury.

Beckman, J. S. (1991) · PubMed · Cited by 463 · see citing works

Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system

Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., et al. (2008) · Nature Immunology · doi:10.1038/ni1551 · Cited by 444 · see citing works

IL-6-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Roles of IL-6 in the Activation and Differentiation of Autoreactive T Cells

Samoilova, E. B., Horton, J. L., Hilliard, B. A., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 441 · see citing works

T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β

Durelli, L., Conti, L., Clerico, M., Boselli, D., Contessa, G., Ripellino, P., Ferrero, B., Eid, P., & Novelli, F. (2009) · Annals of Neurology · doi:10.1002/ana.21652 · Cited by 374 · see citing works

Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.

Tran, E., Hoekstra, K., van Rooijen, N., Dijkstra, C., & Owens, T. (1998) · Journal of Immunology · doi:10.4049/jimmunol.161.7.3767 · Cited by 373 · see citing works

Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia

Rosenberg, G. A., & Yang, Y. R. (2007) · Neurosurgical FOCUS · doi:10.3171/foc.2007.22.5.5 · Cited by 358 · see citing works

Perivascular Spaces and the Two Steps to Neuroinflammation

Owens, T., Bechmann, I., & Engelhardt, B. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818f9ca8 · Cited by 352 · see citing works

Molecular mechanisms involved in T cell migration across the blood–brain barrier

Engelhardt, B. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0409-y · Cited by 344 · see citing works

The paradox of matrix metalloproteinases in infectious disease

Elkington, P. T., O’Kane, C. M., & Friedland, J. S. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02840.x · Cited by 343 · see citing works

Disruption of central nervous system barriers in multiple sclerosis

Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334 · see citing works

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

Lu, F., Selak, M. A., O'Connor, J. J., Croul, S. E., Lorenzana, C., Butunoi, C., & Kálmán, B. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00343-9 · Cited by 331 · see citing works

Radical changes in multiple sclerosis pathogenesis

van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322 · see citing works

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression

van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., & de Vries, H. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.023 · Cited by 316 · see citing works

Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells

Kim, S.-R., Bae, Y.-H., Bae, S., Choi, K.-S., Yoon, K., Koo, T. H., Jang, H.-O., Yun, I., Kim, K.-W., Kwon, Y., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.004 · Cited by 314 · see citing works

Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide

Wong, D. K., & Dorovini‐Zis, K. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90170-p · Cited by 303 · see citing works

Astrocyte-restricted ablation of interleukin-17-induced ACT1-mediated signaling ameliorates autoimmune encephalomyelitis

Kang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.004 · Cited by 297 · see citing works

Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions

Maeda, A., & Sobel, R. A. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199603000-00005 · Cited by 293 · see citing works

Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction

Haorah, J., Knipe, B., Leibhart, J., Ghorpade, A., & Persidsky, Y. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605340 · Cited by 275 · see citing works

Endothelial basement membrane laminin α5 selectively inhibits T lymphocyte extravasation into the brain

Wu, C., Ivars, F., Anderson, P. O., Hallmann, R., Vestweber, D., Nilsson, P., Robenek, H., Tryggvason, K., Song, J., Korpos, É., et al. (2009) · Nature Medicine · doi:10.1038/nm.1957 · Cited by 264 · see citing works

Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.

Pagenstecher, A., Stalder, A. K., Kincaid, C., Shapiro, S., & Campbell, I. L. (1998) · Europe PMC (PubMed Central) · Cited by 263 · see citing works

Angiotensin II Controls Occludin Function and Is Required for Blood–Brain Barrier Maintenance: Relevance to Multiple Sclerosis

Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R. A., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259 · see citing works

Glial Cell Line-Derived Neurotrophic Factor Induces Barrier Function of Endothelial Cells Forming the Blood–Brain Barrier

Igarashi, Y., Utsumi, H., Chiba, H., Yamada-Sasamori, Y., Tobioka, H., Kamimura, Y., Furuuchi, K., Kokai, Y., Nakagawa, T., Mori, M., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0992 · Cited by 252 · see citing works

Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide

Chui, R. W., & Dorovini‐Zis, K. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-1 · Cited by 250 · see citing works

Production and functions of IL-17 in microglia

Kawanokuchi, J., Shimizu, K., Nitta, A., Yamada, K., Mizuno, T., Takeuchi, H., & Suzumura, A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.006 · Cited by 249 · see citing works

The blood-brain barrier, chemokines and multiple sclerosis

Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247 · see citing works

Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor

Wagoner, N. J. V., Oh, J., Repovic, P., & Benveniste, E. N. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05236.1999 · Cited by 244 · see citing works

A Role for Platelets and Endothelial Selectins in Tumor Necrosis Factor-α–Induced Leukocyte Recruitment in the Brain Microvasculature

Tavares, J. C., Hickey, M. J., Hutchison, J. S., Michaud, J., Sutcliffe, I. T., & Kubes, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1141 · Cited by 236 · see citing works

Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale

Man, S., Ubogu, E. E., & Ransohoff, R. M. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00067.x · Cited by 235 · see citing works

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

Waubant, E. L., Goodkin, D., Gee, L., Bacchetti, P., Sloan, R., Stewart, T. J., Andersson, P.-B., Stabler, G., & Miller, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1397 · Cited by 234 · see citing works

Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.

Raine, C. S., Cannella, B., Duijvestijn, A. M., & Cross, A. H. (1990) · PubMed · Cited by 229 · see citing works

MMPs in the central nervous system: Where the good guys go bad

AGRAWAL, S., LAU, L., & Yong, V. W. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.06.003 · Cited by 226 · see citing works

Expression and regulation of toll-like receptors in cerebral endothelial cells

Nagyőszi, P., Wilhelm, I., Farkas, A. E., Fazakas, C., Dung, N. T. K., Haskó, J., & Krizbai, I. A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.002 · Cited by 203 · see citing works

Peroxynitrite formation within the central nervous system in active multiple sclerosis

Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., & Misko, T. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00078-2 · Cited by 201 · see citing works

Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription

Staal, F. J. T., Meeldijk, J., Moerer, P., Jay, P., van de Weerdt, B. C. M., Vainio, S. J., Nolan, G. P., & Clevers, H. C. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1 · Cited by 200 · see citing works

Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate

Azoulay, D., Vachapova, V., Shihman, B., Miler, A., & Karni, A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.001 · Cited by 193 · see citing works

Normobaric hyperoxia attenuates early blood–brain barrier disruption by inhibiting MMP‐9‐mediated occludin degradation in focal cerebral ischemia

Liu, W., Hendren, J. D., Qin, X., Shen, J., & Liu, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05821.x · Cited by 193 · see citing works

Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis

Hendriks, J. J. A., Alblas, J., van der Pol, S. M. A., van Tol, E. A. F., Dijkstra, C. D., & de Vries, H. E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040819 · Cited by 190 · see citing works

Astrocytes and Pericytes Differentially Modulate Blood—Brain Barrier Characteristics during Development and Hypoxic Insult

Al-Ahmad, A. J., Taboada, C. B., Gassmann, M., & Ogunshola, O. O. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.148 · Cited by 183 · see citing works

Reactive oxygen species are required for the phagocytosis of myelin by macrophages

van der Goes, A., Brouwer, J. P., Hoekstra, K., Roos, D., van den Berg, T. K., & Dijkstra, C. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00175-1 · Cited by 180 · see citing works

Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis

Sarma, J. D., Ćirić, B., Marek, R. A., Sadhukhan, S., Caruso, M. L., Shafagh, J., Fitzgerald, D. C., Shindler, K. S., & Rostami, A. M. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-14 · Cited by 173 · see citing works

CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1

Battistini, L. (2003) · Blood · doi:10.1182/blood-2002-10-3309 · Cited by 172 · see citing works

Tumor Necrosis Factor-α Mediates the Blood–Brain Barrier Dysfunction Induced by Activated Microglia in Mouse Brain Microvascular Endothelial Cells

Nishioku, T., Matsumoto, J., Dohgu, S., Sumi, N., Miyao, K., Takata, F., Shuto, H., Yamauchi, A., & Kataoka, Y. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09292sc · Cited by 168 · see citing works

Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity

Schreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., van Kesteren-Hendrikx, E. M. L., Döpp, E. A., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2630 · Cited by 167 · see citing works

Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia

Li, Y., Chu, N., Hu, A., Gran, B., Rostami, A. M., & ZHANG, G. (2006) · Brain · doi:10.1093/brain/awl273 · Cited by 166 · see citing works

Structural and Functional Variations in Capillary Systems within the Braina

Fenstermacher, J. D., Gross, P. M., Sposito, N. M., Acuff, V., Pettersen, S. E., & Gruber, K. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb51416.x · Cited by 162 · see citing works

Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro

van der Goes, A., Wouters, D., van der Pol, S. M. A., Huizinga, R., Ronken, E., Adamson, P., Greenwood, J., Dijkstra, C. D., & de Vries, H. E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0881fje · Cited by 162 · see citing works

Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat

Schulze, C., & Firth, J. A. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.3.773 · Cited by 159 · see citing works

Statins reduce human blood–brain barrier permeability and restrict leukocyte migration: Relevance to multiple sclerosis

Ifergan, I., Wosik, K., Cayrol, R., Kébir, H., Auger, C., Bernard, M., Bouthillier, A., Moumdjian, R. A., Duquette, P., & Prat, A. (2006) · Annals of Neurology · doi:10.1002/ana.20875 · Cited by 158 · see citing works

An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization

Weaver, A., DaSilva, A. G., Nuttall, R. K., Edwards, D. R., Shapiro, S. D., Rivest, S., & Yong, V. W. (2005) · The FASEB Journal · doi:10.1096/fj.04-2030fje · Cited by 156 · see citing works

IL-17 Enhancement of the IL-6 Signaling Cascade in Astrocytes

Ma, X., Reynolds, S. L., Baker, B. J., Li, X., Benveniste, E. N., & Qin, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000142 · Cited by 155 · see citing works

Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier

Nico, B., Frigeri, A., Nicchia, G. P., Quondamatteo, F., Herken, R., Errede, M., Ribatti, D., Svelto, M., & Roncali, L. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.7.1297 · Cited by 154 · see citing works

IL‐21 and IL‐21R are not required for development of Th17 cells and autoimmunity in vivo

Sonderegger, I., Kisielow, J., Meier, R., King, C., & Köpf, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838511 · Cited by 154 · see citing works

A Functional Role for Interleukin-21 in Promoting the Synthesis of the T-Cell Chemoattractant, MIP-3α, by Gut Epithelial Cells

Caruso, R., Fina, D., Peluso, I., Stolfi, C., Fantini, M. C., Gioia, V., Caprioli, F., Blanco, G. D. V., Paoluzi, O. A., MacDonald, T. T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.053 · Cited by 150 · see citing works

On the mode of entry of blood vessels into the cerebral cortex.

Jones, E. G. (1970) · PubMed · Cited by 146 · see citing works

Diapedesis of monocytes is associated with MMP‐ mediated occludin disappearance in brain endothelial cells

Reijerkerk, A., Kooij, G., van der Pol, S. M. A., Khazen, S., Dijkstra, C. D., & de Vries, H. E. (2006) · The FASEB Journal · doi:10.1096/fj.06-6099fje · Cited by 140 · see citing works

Natalizumab and PML

Ransohoff, R. M. (2005) · Nature Neuroscience · doi:10.1038/nn1005-1275 · Cited by 139 · see citing works

Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria

Potter, S. M., Chan‐Ling, T., Ball, H. J., Mansour, H., Mitchell, A. J., Maluish, L., & Hunt, N. H. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.12.005 · Cited by 137 · see citing works

Expression of Vascular Cell Adhesion Molecule-1 (VCAM-1) by Human Brain Microvessel Endothelial Cells in Primary Culture

Wong, D. K., & Dorovini‐Zis, K. (1995) · Microvascular Research · doi:10.1006/mvre.1995.1028 · Cited by 137 · see citing works

Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity

Ferretti, G., Bacchetti, T., Principi, F., DiLudovico, F., Viti, B., Angeleri, V. A., Danni, M. C., & Provinciali, L. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1240oa · Cited by 136 · see citing works

Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen

Vollmer, T. L., Liu, R., Price, M. A., Rhodes, S. N., Cava, A. L., & Shi, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2696 · Cited by 134 · see citing works

Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics

Overall, C. M., McQuibban, G. A., & Clark‐Lewis, I. (2002) · Biological Chemistry · doi:10.1515/bc.2002.114 · Cited by 133 · see citing works

IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain

Tzartos, J., Craner, M., Friese, M., Jakobsen, K. B., Newcombe, J., Esiri, M., & Fugger, L. (2011) · American Journal of Pathology · doi:10.1016/j.ajpath.2010.10.043 · Cited by 131 · see citing works

Regulation of Inflammatory Responses by Oncostatin M

Wallace, P. M., MacMaster, J. F., Rouleau, K. A., Brown, T. J., Loy, J. K., Donaldson, K. L., & Wahl, A. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5547 · Cited by 129 · see citing works

Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis

Huang, W., Huang, P., & Hillert, J. A. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1071oa · Cited by 128 · see citing works

Elevated myeloperoxidase activity in white matter in multiple sclerosis

Gray, E., Thomas, T. L., Betmouni, S., Scolding, N. J., & Love, S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.08.035 · Cited by 125 · see citing works

Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection

Azoulay, D., Urshansky, N., & Karni, A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.01.010 · Cited by 125 · see citing works

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon‐β therapy in relapsing and secondary‐progressive multiple sclerosis patients

Galboiz, Y., Shapiro, S., Lahat, N., Rawashdeh, H., & Miller, A. (2001) · Annals of Neurology · doi:10.1002/ana.1218 · Cited by 125 · see citing works

Elevated serum levels of IFN-γ, IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage

Hohnoki, K., Inoue, A., & Koh, C. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00053-8 · Cited by 121 · see citing works

Tumour necrosis factor-α affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure: Blood-brain barrier in liver failure

Lv, S., Song, H.-L., Zhou, Y., Li, L.-X., Cui, W., Wang, W., & Liu, P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02211.x · Cited by 120 · see citing works

Site-Specific Production of IL-6 in the Central Nervous System Retargets and Enhances the Inflammatory Response in Experimental Autoimmune Encephalomyelitis

Quintana, A., Müller, M., Frausto, R. F., Ramos, R., Getts, D. R., Sanz, E., Hofer, M. J., Krauthausen, M., King, N. J. C., Hidalgo, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900242 · Cited by 119 · see citing works

Dendritic Cell Transmigration through Brain Microvessel Endothelium Is Regulated by MIP-1α Chemokine and Matrix Metalloproteinases

Zozulya, A. L., Reinke, E. K., Baiu, D. C., Kármán, J., Sándor, M., & Fábry, Z. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.520 · Cited by 116 · see citing works

Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes

Ehrlich, S., Infante‐Duarte, C., Seeger, B., & Zipp, F. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00094-2 · Cited by 116 · see citing works

Characteristic gene expression profile of primary human cerebral endothelial cells

Kallmann, B.-A., Wagner, S., Hummel, V., Buttmann, M., Bayas, A., Tonn, J. C., & Rieckmann, P. (2002) · The FASEB Journal · doi:10.1096/fj.01-0594fje · Cited by 113 · see citing works

Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-β) treatment

Özenci, V., Kouwenhoven, M. C. M., Huang, Y.-M., Kivisäkk, P., & Link, H. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01175.x · Cited by 111 · see citing works

Expression of Chemokines and Their Receptors by Human Brain Endothelium: Implications for Multiple Sclerosis

Subileau, E. A., Rezaie, P., Davies, H. A., Colyer, F. M., Greenwood, J., Male, D. K., & Romero, I. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318197eca7 · Cited by 111 · see citing works

Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells

Suidan, G. L., Mcdole, J. R., Chen, Y., Pirko, I., & Johnson, A. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003037 · Cited by 105 · see citing works

Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences

Rubbo, H., Trostchansky, A., & O’Donnell, V. B. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.11.007 · Cited by 105 · see citing works

Management of worsening multiple sclerosis with mitoxantrone: A review

Fox, E. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.04.013 · Cited by 102 · see citing works

Effects of Oncostatin M on Human Cerebral Endothelial Cells and Expression in Inflammatory Brain Lesions

Ruprecht, K., Kuhlmann, T., Seif, F., Hummel, V., Kruse, N., Brück, W., & Rieckmann, P. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.11.1087 · Cited by 102 · see citing works

Microglial activation and increased synthesis of complement component C1q precedes blood–brain barrier dysfunction in rats

Lynch, N. J., Willis, C. L., Nolan, C. C., Roscher, S., Fowler, M. J., Weihe, E., Ray, D. E., & Schwaeble, W. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.08.009 · Cited by 100 · see citing works

Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings

Su, J.-J., Osoegawa, M., Matsuoka, T., Minohara, M., Tanaka, M., Ishizu, T., Mihara, F., Taniwaki, T., & Kira, J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.11.006 · Cited by 99 · see citing works

Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis

Jadidi‐Niaragh, F., & Mirshafiey, A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.005 · Cited by 97 · see citing works

Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis

Greco, A., Minghetti, L., Sette, G., Fieschi, C., & Levi, G. (1999) · Neurology · doi:10.1212/wnl.53.8.1876 · Cited by 97 · see citing works

Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation

Moser, K. V., Reindl, M., Blasig, I. E., & Humpel, C. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.013 · Cited by 95 · see citing works

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis

Lichtinghagen, R., Seifert‐Held, T., Kracke, A., Marckmann, S., Wurster, U., & Heidenreich, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00094-6 · Cited by 95 · see citing works

Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes

Trajković, V., Stošić‐Grujičić, S., Samardžić, T., Marković, M., Miljković, D. M., Ramić, Z., & Stojković, M. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00391-5 · Cited by 94 · see citing works

Brain Pericytes: Emerging Concepts and Functional Roles in Brain Homeostasis

Kamouchi, M., Ago, T., & Kitazono, T. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9605-x · Cited by 92 · see citing works

Augmented expression of tumour necrosis factor-α and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis

Navikas, V., He, B., Link, J., Haglund, M., Söderström, M. B., Fredrikson, S., Ljungdahl, Å., Höjeberg, B., Qiao, J., Olsson, T. P., et al. (1996) · Brain · doi:10.1093/brain/119.1.213 · Cited by 90 · see citing works

Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability

Wong, D., Prameya, R., & Dorovini-Zis, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.003 · Cited by 88 · see citing works

Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis.

Navikas, V., Matusevicius, D., Söderström, M., Fredrikson, S., Kivisäkk, P., Ljungdahl, Å., Hojeberg, B., & Link, H. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00155-7 · Cited by 88 · see citing works

Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

Graesser, D., Mahooti, S., & Madri, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00275-7 · Cited by 88 · see citing works

Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors

Mrass, P., & Weninger, W. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00433.x · Cited by 87 · see citing works

The Beta Chemokines CCL4 and CCL5 Enhance Adhesion of Specific CD4+ T Cell Subsets to Human Brain Endothelial Cells

Quandt, J. A., & Dorovini‐Zis, K. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.350 · Cited by 87 · see citing works

Regulation and Functional Effects of Monocyte Migration across Human Brain-Derived Endothelial Cells

Seguin, R. M., Biernacki, K., Rotondo, R. L., Prat, A., & Antel, J. P. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.412 · Cited by 86 · see citing works

Membrane-type 1-Matrix Metalloproteinase Regulates Intracellular Adhesion Molecule-1 (ICAM-1)-mediated Monocyte Transmigration

Sithu, S. D., English, W., Olson, P. R., Krubasik, D., Baker, A. H., Murphy, G., & D’Souza, S. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611273200 · Cited by 85 · see citing works

EMMPRIN: A Novel Regulator of Leukocyte Transmigration into the CNS in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Agrawal, S. M., Silva, C., Tourtellotte, W., & Yong, W. V. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3659-10.2011 · Cited by 84 · see citing works

OR.41. IL-21 and TGF-β are Required for Differentiation of Human Th17 Cells

Anderson, D., Yang, L., Baecher‐Allan, C., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.03.047 · Cited by 83 · see citing works

The many faces of EMMPRIN—Roles in neuroinflammation

Agrawal, S. M., & Yong, V. W. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.018 · Cited by 82 · see citing works

Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia

Kim, H. S., Cho, I. H., Kim, J., Shin, Y. J., Jeon, J., Kim, Y., Yang, Y. M., Lee, K. H., Lee, S. E., Lee, W.-J., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.009 · Cited by 78 · see citing works

Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma.

Unemori, E., Bair, M. J., Bauer, E. A., & Amento, E. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54522-1 · Cited by 77 · see citing works

Down‐regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type‐1 receptor and nuclear factor‐κB activation

Wachtel, M., Bolliger, M. F., Ishihara, H., Frei, K., Bluethmann, H., & Gloor, S. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00399.x · Cited by 76 · see citing works

Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules

Hummel, V., Kallmann, B. A., Wagner, S., Fuller, T., Bayas, A., Tonn, J.-C., Benveniste, E. N., Toyka, K. V., & Rieckmann, P. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.320 · Cited by 76 · see citing works

Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis

Nygårdas, P., & Hinkkanen, A. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01855.x · Cited by 73 · see citing works

IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier

Linker, R. A., Lühder, F., Kallen, K., Lee, D.-H., Engelhardt, B., Rose‐John, S., & Gold, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.007 · Cited by 73 · see citing works

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-β treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

Krakauer, M., Sørensen, P. S., Khademi, M., Olsson, T. P., & Sellebjerg, F. T. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507087136 · Cited by 73 · see citing works

Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions

Seabrook, T. J., Littlewood-Evans, A., Brinkmann, V., Pöllinger, B., Schnell, C., & HIESTAND, P. C. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-95 · Cited by 73 · see citing works

A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells

Lombardi, A., Cantini, G., Piscitelli, E., Gelmini, S., Francalanci, M., Mello, T., Ceni, E., Varano, G., Forti, G., Rotondi, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.160713 · Cited by 71 · see citing works

Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b

Alexander, J. S., Harris, M., Wells, S., Mills, G. M., Chalamidas, K., Ganta, V. C., McGee, J. C., Jennings, M. H., Gonzalez-Toledo, E., & Minagar, A. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510370791 · Cited by 71 · see citing works

Selective localisation of neuro-specific T lymphocytes in the central nervous system

Ludowyk, P. A., Willenborg, D. O., & Parish, C. R. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90008-9 · Cited by 70 · see citing works

CD8 T Cell-Initiated Vascular Endothelial Growth Factor Expression Promotes Central Nervous System Vascular Permeability under Neuroinflammatory Conditions

Suidan, G. L., Dickerson, J. W., Chen, Y., Mcdole, J. R., Tripathi, P., Pirko, I., Seroogy, K. B., & Johnson, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902773 · Cited by 69 · see citing works

Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease

Monteleone, G., Pallone, F., & MacDonald, T. T. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.002 · Cited by 69 · see citing works

RGMA and IL21R show association with experimental inflammation and multiple sclerosis

Nohra, R. G., Beyeen, A. D., Guo, J. P., Khademi, M., Sundqvist, E., Hedreul, M. T., Sellebjerg, F. T., Smestad, C., Oturai, A. B., Harbo, H. F., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2009.111 · Cited by 66 · see citing works

IFNγ-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells

Bluyssen, H. A. R., Rastmanesh, M. M., Tilburgs, C., Jie, K. E., Wesseling, S., Goumans, M., de Boer, P., Joles, J. A., & Braam, B. G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00513.2009 · Cited by 66 · see citing works

Ultrastructure of the blood-brain barrier in the rabbit.

Sedlakova, R., Shivers, R. R., & Maestro, R. F. D. (1999) · PubMed · Cited by 66 · see citing works

Matrix metalloproteinase‐19 is highly expressed in active multiple sclerosis lesions

van Horssen, J., Vos, C. M. P., Admiraal, L., van Haastert, E. S., Montagne, L., van der Valk, P., & de Vries, H. E. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00766.x · Cited by 64 · see citing works

IL‐21 Modulates CD4+ CD25+ Regulatory T‐Cell Homeostasis in Experimental Autoimmune Encephalomyelitis

Piao, W., Jee, Y., Liu, R. L., Coons, S. W., Kala, M., Collins, M. A., Young, D. A., Campagnolo, D. I., Vollmer, T. L., Bai, X., et al. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.02035.x · Cited by 63 · see citing works

FOXO1 plays an essential role in apoptosis of retinal pericytes.

Alikhani, M., Roy, S., & Graves, D. T. (2010) · PubMed Central · Cited by 63 · see citing works

Metalloproteinases and their Tissue Inhibitors in Multiple Sclerosis

Özenci, V., Rinaldi, L., Teleshova, N., Matusevičius, D., Kivisäkk, P., Kouwenhoven, M. C. M., & Link, H. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0285 · Cited by 62 · see citing works

Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1.

Rattan, V., Sultana, C., Shen, Y. M., & Kalra, V. K. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.3.e453 · Cited by 62 · see citing works

IL17 and IFNγ production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis

Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Marti, A., Caggiula, M., Massimiliano Mirabella, A., Tonali, P. A., & Batocchi, A. P. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.007 · Cited by 61 · see citing works

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation

Hoffmann, O. M., Zipp, F., & Weber, J. R. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0484-x · Cited by 61 · see citing works

Angiostatic activity of the antitumor cytokine interleukin-21

Castermans, K., Tabruyn, S. P., Zeng, R., B, J. R. V. B., Eppolito, C., Leonard, W. J., Shrikant, P. A., & Griffioen, A. W. (2008) · Blood · doi:10.1182/blood-2007-09-113878 · Cited by 60 · see citing works

Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis

Alonso, Á., Jick, S. S., & Hernán, M. Á. (2006) · Neurology · doi:10.1212/01.wnl.0000198507.13597.45 · Cited by 60 · see citing works

Astrocytes in the tempest of multiple sclerosis

Miljković, D. M., Timotijević, G. S., & Stojković, M. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.047 · Cited by 60 · see citing works

Granzyme B mediates neurotoxicity through a G‐protein‐coupled receptor

Wang, T.-G., Allie, R., Conant, K., Haughey, N., Turchan-Cholewo, J., Hahn, K., Rosen, A., Steiner, J., Keswani, S., Jones, M. V., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5022fje · Cited by 60 · see citing works

Free oxygen radicals decrease electrical resistance of microvascular endothelium in brain

Olesen, S. (1987) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1987.tb08057.x · Cited by 59 · see citing works

Opening of the blood-brain barrier during cortical superfusion with histamine

Schilling, L., & Wahl, M. (1994) · Brain Research · doi:10.1016/0006-8993(94)90403-0 · Cited by 58 · see citing works

Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers

Wang, T., Lee, M.-H., Johnson, T., Allie, R., Hu, L., Calabresi, P. A., & Nath, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0311-10.2010 · Cited by 58 · see citing works

Endothelial histamine H 1 receptor signaling reduces blood–brain barrier permeability and susceptibility to autoimmune encephalomyelitis

Lu, C., Diehl, S. A., Noubade, R., Ledoux, J., Nelson, M. T., Spach, K. M., Zachary, J. F., Blankenhorn, E. P., & Teuscher, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008816107 · Cited by 58 · see citing works

IL‐27 inhibits OSM‐mediated TNF‐α and iNOS gene expression in microglia

Baker, B. J., Park, K. W., Qin, H., Ma, X., & Benveniste, E. N. (2010) · Glia · doi:10.1002/glia.20989 · Cited by 57 · see citing works

THE INFLUENCE OF OXYGEN FREE RADICALS ON THE PERMEABILITY OF THE MONOLAYER OF CULTURED BRAIN ENDOTHELIAL CELLS

Imaizumi, S., Kondo, T., Deli, M. A., Gobbel, G. T., Joó, F., Epstein, C. J., Yoshimoto, T., & Chan, P. H. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00120-4 · Cited by 53 · see citing works

Expression of IFN-gamma in Cerebrovascular Endothelial Cells from Aged Mice

Wei, Y., Kita, M., Shinmura, K., Yan, X.-Q., Fukuyama, R., Fushiki, S., & Imanishi, J. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/107999000312342 · Cited by 52 · see citing works

Inflammatory Cytokines and HIV-1-Associated Neurodegeneration: Oncostatin-M Produced by Mononuclear Cells from HIV-1-Infected Individuals Induces Apoptosis of Primary Neurons

Ensoli, F., Valeria Fiorelli, A., DeCristofaro, M., Muratori, D. S., Novi, A., Vannelli, B., Thiele, C. J., Luzi, G., & Aiuti, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6268 · Cited by 51 · see citing works

Neurotrophic factors attenuate microvascular permeability disturbances and axonal injury following trauma to the rat spinal cord

SHARMA, H. S. (2003) · Springer eBooks · doi:10.1007/978-3-7091-0651-8_81 · Cited by 50 · see citing works

Increase of tumor necrosis factor-α in the blood induces the early activation of matrix metalloproteinase-9 in the brain

Tsuge, M., Yasui, K., Ichiyawa, T., Saito, Y., Nagaoka, Y., Yashiro, M., Yamashita, N., & Morishima, T. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00226.x · Cited by 49 · see citing works

Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia

Lee, H., Kim, H. J., Kim, J., & Chang, N. (2003) · Brain Research · doi:10.1016/j.brainres.2003.10.027 · Cited by 48 · see citing works

Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo

Weiss, T. W., Samson, A. L., Niego, B., Daniel, P. B., & Medcalf, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-5850fje · Cited by 48 · see citing works

A Pilot, Open Label, Clinical Trial Using Hydroxyzine in Multiple Sclerosis

Logothetis, I., Mylonas, I. A., Baloyannis, S., Pashalidou, M., Orologas, A., Ζαφειρόπουλος, Α., Kosta, V., & Theoharides, T. C. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800421 · Cited by 48 · see citing works

Differential expression of interferon-γ receptor on human glial cells in vivo and in vitro

Hashioka, S., Klegeris, A., Schwab, C., Yu, S. Y., & McGeer, P. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.023 · Cited by 47 · see citing works

Deficient p75 low-affinity neurotrophin receptor expression exacerbates experimental allergic encephalomyelitis in C57/BL6 mice

Copray, S. C. V. M., Küst, B., Emmer, B. J., Lin, M. Y., Liem, R. S. B., Amor, S., de Vries, H. E., Floris, S., & Boddeke, E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.008 · Cited by 47 · see citing works

Nerve growth factor antibody exacerbates neuropathological signs of experimental allergic encephalomyelitis in adult Lewis rats

Micera, A., Properzi, G., Triaca, V., & Aloe, L. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00272-6 · Cited by 45 · see citing works

Inflammation in the Central Nervous System and Th17 Responses Are Inhibited by IFN-γ–Induced IL-18 Binding Protein

Millward, J. M., Løbner, M., Wheeler, R. D., & Owens, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902153 · Cited by 44 · see citing works

TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis

Kikuchi, S., Miyagishi, R., Fukazawa, T., Yabe, I., Miyazaki, Y., & Sasaki, H. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.021 · Cited by 44 · see citing works

Shear stress‐induced shedding of soluble intercellular adhesion molecule‐1 from saphenous vein endothelium

Sultan, S., Gosling, M., Nagase, H., & Powell, J. T. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00337-0 · Cited by 43 · see citing works

Regulation of Cellular and Molecular Trafficking across Human Brain Endothelial Cells by Th1‐ and Th2‐Polarized Lymphocytes

Biernacki, K., Prat, A., Blain, M., & Antel, J. (2004) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/63.3.223 · Cited by 43 · see citing works

STAT3 inhibitors attenuate interferon-γ-induced neurotoxicity and inflammatory molecule production by human astrocytes

Hashioka, S., Klegeris, A., Qing, H., & McGeer, P. L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.018 · Cited by 42 · see citing works

Oncostatin M is a novel glucocorticoid-dependent neuroinflammatory factor that enhances oligodendrocyte precursor cell activity in demyelinated sites

Glezer, I., & Rivest, S. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.01.005 · Cited by 42 · see citing works

Death receptor expression and function at the human blood brain barrier

Wosik, K., Biernacki, K., Khouzam, M.-P., & Prat, A. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.08.018 · Cited by 41 · see citing works

Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice

Thorne, M., Moore, C. S., & Robertson, G. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.04.003 · Cited by 40 · see citing works

Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers

Alvarez, J. I., & Teale, J. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.036 · Cited by 39 · see citing works

Death of PC12 cells and hippocampal neurons induced by adenoviral-mediated FAD human amyloid precursor protein gene expression

Luo, J. J., Wallace, W., Riccioni, T., Ingram, D. K., Roth, G. S., & Kusiak, J. W. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990301)55:5 · Cited by 39 · see citing works

IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis

Liu, R., Bai, Y., Vollmer, T. L., Bai, X., Jee, Y., Tang, Y., Campagnolo, D. I., Collins, M. A., Young, D. A., Cava, A. L., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.004 · Cited by 39 · see citing works

The protective effects of interleukin-18 and interferon-γ on neuronal damages in the rat hippocampus following status epilepticus

Ryu, H. J., Kim, J.-E., Kim, M.-J., Kwon, H., Suh, S. W., Song, H., & Kang, T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.048 · Cited by 37 · see citing works

Human NK Cells Lyse Organ-Specific Endothelial Cells: Analysis of Adhesion and Cytotoxic Mechanisms

Bielawska‐Pohl, A., Silva, C. C. D., Caignard, A., Gaudin, C., Duś, D., Kiéda, C., & Chouaı̈b, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5573 · Cited by 37 · see citing works

Interleukin‐6‐type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function

Moidunny, S., Dias, R. B., Wesseling, E. M., Sekino, Y., Boddeke, H. W. G. M., Sebastião, A. M., & Biber, K. P. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06881.x · Cited by 36 · see citing works

Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis

Kahl, K. G., Kruse, N., Toyka, K. V., & Rieckmann, P. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00136-3 · Cited by 34 · see citing works

Oncostatin M induces functional and structural impairment of blood–brain barriers comprised of rat brain capillary endothelial cells

Takata, F., Sumi, N., Nishioku, T., Harada, E., Wakigawa, T., Shuto, H., Yamauchi, A., & Kataoka, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.030 · Cited by 34 · see citing works

Apoptosis-related molecules in blood in multiple sclerosis

Hagman, S., Kuusisto, H., Raunio, M., Paalavuo, R., Levula, M., Lehtimäki, T. J., & Elovaara, I. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.002 · Cited by 32 · see citing works

Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor α and interferon γ in human microvascular endothelium

Lombardi, A., Cantini, G., Mello, T., Francalanci, M., Gelmini, S., Cosmi, L., Santarlasci, V., Degl’Innocenti, S., Luciani, P., Deledda, C., et al. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.07.004 · Cited by 30 · see citing works

Evidence for the involvement of histamine in the regulation of blood-brain barrier permeability

Gulati, A., Dhawan, K. N., Shukla, R., Srimal, R. C., & Dhawan, B. N. (1985) · Pharmacological Research Communications · doi:10.1016/0031-6989(85)90019-0 · Cited by 30 · see citing works

Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors α and β, and interferon γ

Ensoli, F., Valeria Fiorelli, A., Lugaresi, A., Farina, D., Cristofaro, M. D., Collacchi, B., Muratori, D. S., Scala, E., Gioacchino, M. D., Paganelli, R., et al. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms817oa · Cited by 30 · see citing works

Microglia express a functional receptor for interleukin-23

Sonobe, Y., Liang, J., Jin, S., Zhang, G., Takeuchi, H., Mizuno, T., & Suzumura, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.059 · Cited by 29 · see citing works

Cytokine and IL-12 receptor mRNA discriminate between different clinical subtypes in multiple sclerosis

van Boxel-Dezaire, A. H. H., Smits, M., Trigt-Hoff, S. C. J. V., Killestein, J., van Houwelingen, H. C., Polman, C. H., & Nagelkerken, L. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00398-8 · Cited by 29 · see citing works

Long-Term Expression of Tissue-Inhibitor of Matrix Metalloproteinase-1 in the Murine Central Nervous System Does Not Alter the Morphological and Behavioral Phenotype but Alleviates the Course of Experimental Allergic Encephalomyelitis

Althoff, G. E. M., Wolfer, D. P., Timmesfeld, N., Kanzler, B., Schrewe, H., & Pagenstecher, A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090918 · Cited by 27 · see citing works

Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation

Lapilla, M., Gallo, B. M., Martinello, M., Procaccini, C., Costanza, M., Musio, S., Rossi, B., Angiari, S., Farina, C., Steinman, L., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910486 · Cited by 27 · see citing works

Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis

Doerck, S., Göbel, K., Weise, G., Schneider‐Hohendorf, T., Reinhardt, M., Hauff, P., Schwab, N., Linker, R. A., Mäurer, M., Meuth, S. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015478 · Cited by 27 · see citing works

The blood-brain barrier

Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437 · see citing works

Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms

Huang, X., Hussain, B., & Chang, J. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13569 · Cited by 732 · see citing works

Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works

The dynamic blood–brain barrier

Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616 · see citing works

The impact of microglial activation on blood-brain barrier in brain diseases

da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572 · see citing works

Glial influence on the blood brain barrier

Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 542 · see citing works

Progress towards biocompatible intracortical microelectrodes for neural interfacing applications

Jorfi, M., Skousen, J. L., Weder, C., & Capadona, J. R. (2015) · Journal of Neural Engineering · doi:10.1088/1741-2560/12/1/011001 · Cited by 384 · see citing works

Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming

Roy, D. G., Chen, J., Mamane, V. H., Ma, E. H., Muhire, B. M., Sheldon, R. D., Shorstova, T., Koning, R., Johnson, R. M., Esaulova, E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.006 · Cited by 347 · see citing works

Redox Control of Microglial Function: Molecular Mechanisms and Functional Significance

Rojo, A. I., McBean, G. J., Cindrić, M., Egea, J., López, M. G., Rada, P., Žarković, N., & Cuadrado, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5745 · Cited by 313 · see citing works

Factors controlling permeability of the blood–brain barrier

Almutairi, M. M., Chen, G., Xu, Y. G., Chang, Y., & Shi, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2050-8 · Cited by 308 · see citing works

Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease

Matt, S. M., & Gaskill, P. J. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09851-4 · Cited by 286 · see citing works

Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment

Lampron, A., ElAli, A., & Rivest, S. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.005 · Cited by 282 · see citing works

Blood-brain barrier permeability and physical exercise

Małkiewicz, M. A., Szarmach, A., Sabisz, A., Cubała, W. J., Szurowska, E., & Winklewski, P. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1403-x · Cited by 276 · see citing works

Neutrophils Mediate Blood–Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases

Aubé, B., Lévesque, S. A., Paré, A., Chamma, É., Kébir, H., Gorina, R., Lécuyer, M., Alvarez, J. I., Koninck, Y. D., Engelhardt, B., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400401 · Cited by 229 · see citing works

Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI

Cramer, S. P., Simonsen, H., Frederiksen, J. L., Rostrup, E., & Larsson, H. B. W. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.12.001 · Cited by 232 · see citing works

T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention

van Langelaar, J., de Vries, R. M. V. D. V., Janssen, M., Wierenga‐Wolf, A. F., Spilt, I. M., Siepman, T. A. M., Dankers, W., Verjans, G. M. G. M., de Vries, H. E., Lubberts, E., et al. (2018) · Brain · doi:10.1093/brain/awy069 · Cited by 224 · see citing works

Vascular disruption and blood–brain barrier dysfunction in intracerebral hemorrhage

Keep, R. F., Zhou, N., Xiang, J., Andjelkovic, A. V., Hua, Y., & Xi, G. (2014) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-11-18 · Cited by 220 · see citing works

T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy

Sackstein, R., Schatton, T., & Barthel, S. R. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.25 · Cited by 213 · see citing works

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205 · see citing works

A basic overview of multiple sclerosis immunopathology

Grigoriadis, N., & Pesch, V. V. (2015) · European Journal of Neurology · doi:10.1111/ene.12798 · Cited by 204 · see citing works

Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications

Cristante, E., McArthur, S., Mauro, C., Maggioli, E., Romero, I. A., Wylezinska, M., Couraud, P. O., Lopez-Tremoleda, J., Christian, H., Weksler, B. B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209362110 · Cited by 197 · see citing works

Multiple Sclerosis and T Lymphocytes: An Entangled Story

Legroux, L., & Arbour, N. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9614-0 · Cited by 196 · see citing works

Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases

Chen, T., Dai, Y., Hu, C., Lin, Z., Wang, S., Yang, J., Zeng, L., Li, S., & Li, W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00557-1 · Cited by 201 · see citing works

Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 192 · see citing works

The innate immune system in demyelinating disease

Mayo, L., Quintana, F. J., & Weiner, H. L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01135.x · Cited by 184 · see citing works

Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption

de Souza, P. S., Gonçalves, E. D., Pedroso, G. S., Farias, H. R., Junqueira, S. C., Marcon, R., Tuon, T., Cola, M., Silveira, P. C. L., Santos, A. R. S., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0014-0 · Cited by 176 · see citing works

Brain metastasis: Unique challenges and open opportunities

Lowery, F. J., & Yu, D. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.001 · Cited by 171 · see citing works

The Paradox of HIV Blood–Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies

Osborne, O., Peyravian, N., Nair, M., Daunert, S., & Toborek, M. J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.007 · Cited by 168 · see citing works

Glial influences on BBB functions and molecular players in immune cell trafficking

Lécuyer, M., Kébir, H., & Prat, A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.004 · Cited by 163 · see citing works

Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis

Lovelace, M. D., Varney, B., Sundaram, G., Franco, N. F., Ng, M. L., Pai, S., Lim, C. K., Guillemin, G. J., & Brew, B. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00246 · Cited by 154 · see citing works

Benchmarking in vitro tissue-engineered blood–brain barrier models

DeStefano, J. G., Jamieson, J. J., Linville, R. M., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0117-2 · Cited by 142 · see citing works

VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells

Schneider‐Hohendorf, T., Rossaint, J., Mohan, H., Böning, D., Breuer, J., Kuhlmann, T., Groß, C. C., Flanagan, K., Sorokin, L. M., Vestweber, D., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140540 · Cited by 141 · see citing works

The role of RANK ligand/osteoprotegerin in rheumatoid arthritis

Geusens, P. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12438080 · Cited by 144 · see citing works

The contribution of neutrophils to CNS autoimmunity

Pierson, E. R., Wagner, C. A., & Goverman, J. M. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.06.017 · Cited by 139 · see citing works

MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis

Reijerkerk, A., Lopez-Ramirez, M. A., van het Hof, B., Drexhage, J. A. R., Kamphuis, W. W., Kooij, G., Vos, J. B., van der Pouw Kraan, T. C. T. M., van Zonneveld, A. J., Horrevoets, A. J., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3965-12.2013 · Cited by 138 · see citing works

Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial

Sanoobar, M., Eghtesadi, S., Azimi, A., Khalili, M., Khodadadi, B., Jazayeri, S., Gohari, M. R., & Aryaeian, N. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000106 · Cited by 135 · see citing works

An unsupervised machine learning method for discovering patient clusters based on genetic signatures

Lopez, C. E., Tucker, S. M., Salameh, T. J., & Tucker, C. S. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.07.004 · Cited by 134 · see citing works

Brain-Reactive Antibodies and Disease

Diamond, B., Honig, G., Mader, S., Brimberg, L., & Volpe, B. T. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075041 · Cited by 134 · see citing works

IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments

Luchtman, D. W., Ellwardt, E., Larochelle, C., & Zipp, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.013 · Cited by 133 · see citing works

Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology

Deczkowska, A., Baruch, K., & Schwartz, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.006 · Cited by 125 · see citing works

Multiple sclerosis: molecular pathogenesis and therapeutic intervention

Boutitah-Benyaich, I., Eixarch, H., Villacieros‐Álvarez, J., Hervera, A., Cobo‐Calvo, Á., Montalbán, X., & Espejo, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02415-4 · Cited by 136 · see citing works

CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation

Wu, F., Zhao, Y., Jiao, T., Shi, D., Zhu, X., Zhang, M., Shi, M., & Zhou, H. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0316-6 · Cited by 124 · see citing works

Developmental and pathological angiogenesis in the central nervous system

Vallon, M., Chang, J., Zhang, J. H., & Kuo, C. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1625-0 · Cited by 124 · see citing works

The formation of inflammatory demyelinated lesions in cerebral white matter

Maggi, P., Macri, S. M. C., Gaitán, M. I., Leibovitch, E., Wholer, J. E., Knight, H. L., Ellis, M., Wu, T., Silva, A. C., Massacesi, L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24242 · Cited by 110 · see citing works

Untitled work

Fan (2020) · doi:10.3389/fnmol.2020.00090

In vitro Models of the Blood–Brain Barrier: Tools in Translational Medicine

Williams-Medina, A. R., Deblock, M. C., & Janigro, D. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.623950 · Cited by 106 · see citing works

Albumin and multiple sclerosis

LeVine, S. M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0564-9 · Cited by 105 · see citing works

Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis

Lécuyer, M., Saint‐Laurent, O., Bourbonnière, L., Larouche, S., Larochelle, C., Michel, L., Charabati, M., Abadier, M., Zandee, S., Jahromi, N. H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614336114 · Cited by 105 · see citing works

Blood–brain barrier and its function during inflammation and autoimmunity

Sonar, S. A., & Lal, G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru1117-428r · Cited by 107 · see citing works

Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis

Alrouji, M., Manouchehrinia, A., Gran, B., & Constantinescu, C. S. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.10.004 · Cited by 105 · see citing works

A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis

Miller, E., Dziedzic, A., Saluk-Bijak, J., & Bijak, M. (2019) · Nutrients · doi:10.3390/nu11071528 · Cited by 92 · see citing works

Exposure of neonatal rats to alcohol has differential effects on neuroinflammation and neuronal survival in the cerebellum and hippocampus

Topper, L. A., Baculis, B. C., & Valenzuela, C. F. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0382-9 · Cited by 101 · see citing works

Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing–remitting multiple sclerosis

Sanoobar, M., Eghtesadi, S., Azimi, A., Khalili, M., Jazayeri, S., & Gohari, M. R. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.801844 · Cited by 100 · see citing works

Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)

Bondt, M. D., Hellings, N., Opdenakker, G., & Struyf, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124558 · Cited by 100 · see citing works

Molecular alterations of the blood–brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition

Troletti, C. D., de Goede, P., Kamermans, A., & de Vries, H. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.010 · Cited by 97 · see citing works

Blood-brain barrier disruption: a culprit of cognitive decline?

Che, J., Sun, Y., Deng, Y., & Zhang, J. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00563-3 · Cited by 103 · see citing works

Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients

Celarain, N., & Tomàs-Roig, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1667-1 · Cited by 87 · see citing works

Brain Endothelial miR-146a Negatively Modulates T-Cell Adhesion through Repressing Multiple Targets to Inhibit NF-κB Activation

Wu, D., Cerutti, C., Lopez‐Ramirez, M. A., Pryce, G., King‐Robson, J., Simpson, J. E., van der Pol, S. M. A., Hirst, M. C., de Vries, H. E., Sharrack, B., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.207 · Cited by 89 · see citing works

Innate IFN‐γ promotes development of experimental autoimmune encephalomyelitis: A role for NK cells and M1 macrophages

Dungan, L. S., McGuinness, N., Boon, L., Lynch, M. A., & Mills, K. H. G. (2014) · European Journal of Immunology · doi:10.1002/eji.201444612 · Cited by 88 · see citing works

T Cell Recruitment in the Brain during Normal Aging

Gemechu, J. M., & Bentivoglio, M. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00038 · Cited by 86 · see citing works

The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication

Kargapolova, Y., Geißen, S., Zheng, R., Baldus, S. E., Winkels, H., & Adam, M. (2021) · Antioxidants · doi:10.3390/antiox10040562 · Cited by 85 · see citing works

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions

Roncato, R., Angelini, J., Pani, A., Cecchin, E., Bianchi, A. S., Siena, S., Mattia, E. D., Scaglione, F., & Toffoli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176350 · Cited by 83 · see citing works

Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke

Sarvari, S., Moakedi, F., Hone, E., Simpkins, J. W., & Ren, X. S. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00573-8 · Cited by 83 · see citing works

The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases

Sommer, A., Winner, B., & Prots, I. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0222-8 · Cited by 80 · see citing works

Blood–Brain Barrier Disruption in Neuroimmunological Disease

Shimizu, F., & Nakamori, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910625 · Cited by 82 · see citing works

Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women

Chupel, M. U., Minuzzi, L. G., Furtado, G. E., Santos, M. L. A. S., Hogervorst, E., Filaire, E., & Teixeira, A. M. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0775 · Cited by 78 · see citing works

The Blood–Brain Barrier: Composition, Properties, and Roles in Brain HealthPreprint

Lacoste, B., Prat, A., Andrade, M. F., & Gu, C. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041422 · Cited by 79 · see citing works

Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons

Gu, W., Luozhong, S., Cai, S., Londhe, K., Elkasri, N., Hawkins, R. D., Yuan, Z., Greene, K. S., Yin, Y., Cruz, M., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01150-x · Cited by 76 · see citing works

Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis

Bergsland, N., Dwyer, M. G., Jakimovski, D., Tavazzi, E., Benedict, R. H. B., Weinstock‐Guttman, B., & Zivadinov, R. (2022) · Neurology · doi:10.1212/wnl.0000000000201608 · Cited by 73 · see citing works

Gluten‐induced cognitive impairment (“brain fog”) in coeliac disease

Yelland, G. W. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13706 · Cited by 75 · see citing works

Lipid nanocapsules to enhance drug bioavailability to the central nervous system

Moura, R. P., Pacheco, C., Pêgo, A. P., Rieux, A. D., & Sarmento, B. F. C. C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.042 · Cited by 72 · see citing works

Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single‐cell transcriptome analysis

Ruan, H., Zhou, Y., Shen, J., Zhai, Y., Xu, Y., Pi, L., Huang, R., Chen, K., Li, X., Ma, W., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.246 · Cited by 70 · see citing works

The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update

Sangha, A., Quon, M., Pfeffer, G., & Orton, S. M. (2023) · Nutrients · doi:10.3390/nu15132978 · Cited by 78 · see citing works

Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced in Vitro by Combined 5-Aza-2′-Deoxycytidine and Interferon-γ Treatments

Wastowski, I. J., Simões, R. T., Yaghi, L., Donadi, E. A., Pancoto, J. A. T., Poras, I., Lechapt, E., Bernaudin, M., Valable, S., Carlotti, C. G., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.10.021 · Cited by 71 · see citing works

Blood–brain barrier dysfunction in immuno-mediated neurological diseases

Shimizu, F., Nishihara, H., & Kanda, T. (2018) · Immunological Medicine · doi:10.1080/25785826.2018.1531190 · Cited by 69 · see citing works

Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection

Pacheco‐Herrero, M., Soto-Rojas, L. O., Harrington, C. R., Flores-Martinez, Y. M., Villegas-Rojas, M. M., León-Aguilar, A. M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Corniel-Taveras, C. N., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.660087 · Cited by 69 · see citing works

Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD4-selective WNT surrogate in mice

Ding, J., Lee, S., Vlahos, L. J., Yuki, K., Rada, C. C., van Unen, V., Vuppalapaty, M., Chen, H., Sura, A., McCormick, A. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37689-1 · Cited by 68 · see citing works

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis

Núñez, C., Stephan‐Otto, C., Usall, J., Bioque, M., Lobo, A., González-Pinto, A. M., Pina‐Camacho, L., Vieta, E., Castro‐Fornieles, J., Rodríguez–Jiménez, R., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby113 · Cited by 68 · see citing works

Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation

Larochelle, C., Wasser, B., Jamann, H., Löffel, J. T., Cui, Q., Tastet, O., Schillner, M., Luchtman, D. W., Birkenstock, J., Stroh, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025813118 · Cited by 68 · see citing works

Biosensors Integration in Blood–Brain Barrier-on-a-Chip: Emerging Platform for Monitoring Neurodegenerative Diseases

Mir, M., Palma-Florez, S., Lagunas, A., Lopez-Martinez, M. J., & Samitier, J. (2022) · ACS Sensors · doi:10.1021/acssensors.2c00333 · Cited by 67 · see citing works

Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers

Michel, L., Grasmuck, C., Charabati, M., Lécuyer, M., Zandee, S., Dhaeze, T., Alvarez, J. I., Li, R., Larouche, S., Bourbonnière, L., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0475 · Cited by 66 · see citing works

Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform

Choi, A., Javius-Jones, K., Hong, S., & Park, H. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s394389 · Cited by 67 · see citing works

The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators

Kamphuis, W. W., Troletti, C. D., Reijerkerk, A., Romero, I. A., & de Vries, H. E. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150116125246 · Cited by 65 · see citing works

Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity

Waisman, A., & Johann, L. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1709-7 · Cited by 66 · see citing works

Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies

Majerová, P., Michalicová, A., Cente, M., Hanes, J., Vegh, J., Kittel, Á., Kosikova, N., Cigánková, V., Mihaljević, S., Jadhav, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217216 · Cited by 67 · see citing works

Impact of Tau on Neurovascular Pathology in Alzheimer's Disease

Canepa, E., & Fossati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573324 · Cited by 65 · see citing works

Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies

Futtrup, J., Margolinsky, R., Benros, M. E., Moos, T., Routhe, L. G., Rungby, J., & Krogh, J. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100102 · Cited by 64 · see citing works

Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug‐resistant epilepsy

Ouédraogo, O., Rébillard, R., Jamann, H., Mamane, V. H., Clénet, M., Daigneault, A., Lahav, B., Uphaus, T., Steffen, F., Bittner, S., et al. (2020) · Epilepsia · doi:10.1111/epi.16742 · Cited by 64 · see citing works

Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article

Bagheri, S., Haddadi, R., Saki, S., Kourosh‐Arami, M., Rashno, M., Mojaver, A., & Komaki‬, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1188839 · Cited by 70 · see citing works

Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal

Larochelle, C., Metz, I., Lécuyer, M., Terouz, S., Roger, M., Arbour, N., Brück, W., & Prat, A. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516641775 · Cited by 64 · see citing works

Exercise-induced changes in neurotrophic factors and markers of blood-brain barrier permeability are moderated by weight status in multiple sclerosis.

Mokhtarzade, M., Motl, R., Negaresh, R., Zimmer, P., Khodadoost, M., Baker, J., Patel, D. I., Majdinasab, N., & Ranjbar, R. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.05.010 · Cited by 25 · see citing works

The Tri-phasic Role of Hydrogen Peroxide in Blood-Brain Barrier Endothelial cells

Shaji, C. A., Robinson, B. D., Yeager, A., Beeram, M., Davis, M. L., Isbell, C. L., Huang, J. H., & Tharakan, B. (2019) · Scientific Reports · doi:10.1038/s41598-018-36769-3 · Cited by 64 · see citing works

Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration

Winkler, A., Wrzos, C., Haberl, M., Weil, M., Gao, M., Möbius, W., Odoardi, F., Thal, D. R., Chang, M., Opdenakker, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141694 · Cited by 60 · see citing works

Inflammation as common link to progressive neurological diseases

Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03628-8 · Cited by 60 · see citing works

The emerging role of neutrophils in neurodegeneration

Rossi, B., Constantin, G., & Zenaro, E. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.10.014 · Cited by 59 · see citing works

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

Valentin-Torres, A., Savarin, C., Hinton, D. R., Phares, T. W., Bergmann, C. C., & Stohlman, S. A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0513-y · Cited by 58 · see citing works

Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Komi, D. E. A., & Cao, Y. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8595-y · Cited by 58 · see citing works

The tale of histone modifications and its role in multiple sclerosis

He, H., Hu, Z., Han, X., Zhou, F., & Yang, B. (2018) · Human Genomics · doi:10.1186/s40246-018-0163-5 · Cited by 58 · see citing works

Trojan Horse Monocyte-Mediated Delivery of Conjugated Polymer Nanoparticles for Improved Photodynamic Therapy of Glioblastoma

Ibarra, L. E., Beaugé, L., Arias‐Ramos, N., Rivarola, V. A., Chesta, C. A., López‐Larrubia, P., & Palacios, R. E. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0106 · Cited by 58 · see citing works

The blood–brain-barrier in multiple sclerosis: Functional roles and therapeutic targeting

Correale, J., & Villa, A. (2007) · Autoimmunity · doi:10.1080/08916930601183522 · Cited by 167 · see citing works

Blood-brain barrier disruption in multiple sclerosis

Minagar, A., & Alexander, J. S. (2003) · Multiple Sclerosis · doi:10.1191/1352458503ms965oa · Cited by 685 · see citing works

Role of the Blood–Brain Barrier in Multiple Sclerosis

Ortiz, G. G., Pacheco-Moisés, F. P., Macías-Islas, M. Á., Flores-Alvarado, L. J., Mireles-Ramírez, M. A., González-Renovato, E. D., Hernández-Navarro, V. E., Sánchez-López, A. L., & Alatorre-Jiménez, M. A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.013 · Cited by 373 · see citing works

Blood-brain barrier disruption in multiple sclerosis. Multiple Sclerosis 9:540–549

Minagar, A., & Alex, J. S. (2003)

Blood-brain barrier disruption in multiple sclerosis, Multiple Sclerosis 9 (2003), 540–549. E. Waubant / Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis 243

Minagar, A., & Alex, J. S. (2016)